Search

for
Search:

Products matching "setipiprant"

Tracking 1 products like 264 Setipiprant Powder – 5g from by companies like Anageninc. View product »

Sort by

Research

360-390 / 1000+ results

research Finasteride

August 2013 in “Reactions Weekly”

research Finasteride

January 2013 in “Reactions Weekly”

research Finasteride

December 2012 in “Reactions Weekly”

research Finasteride

August 2012 in “Reactions Weekly”

research Finasteride

March 2012 in “Reactions Weekly”

research Finasteride

August 2011 in “Reactions Weekly”

research Finasteride

May 2011 in “Reactions Weekly”

research Finasteride

April 2011 in “Reactions Weekly”

research Finasteride

March 2011 in “Reactions Weekly”

research Finasteride

April 2010 in “Reactions Weekly”

research Finasteride

September 2009 in “Reactions Weekly”

research Finasteride

August 2009 in “Reactions Weekly”

research Finasteride

February 2009 in “Reactions Weekly”

research Finasteride

October 2008 in “Reactions Weekly”

research Finasteride

October 2008 in “Reactions Weekly”

research Finasteride

February 2008 in “Reactions Weekly”

research Finasteride

November 2007 in “Reactions Weekly”

research Finasteride

January 2004 in “Reactions Weekly”

research Finasteride

March 2003 in “Reactions Weekly”

research Finasteride

October 2002 in “Reactions Weekly”

research Finasteride

September 2002 in “Reactions Weekly”

research Finasteride

February 2023 in “Reactions Weekly”

research Finasteride

January 2023 in “Reactions Weekly”

research Finasteride

May 2022 in “Reactions Weekly”

research Finasteride

December 2021 in “Reactions Weekly”

research Finasteride

April 2015 in “Reactions Weekly”

research Finasteride

May 2013 in “Reactions Weekly”

research Finasteride

December 2012 in “Reactions Weekly”

research Finasteride

January 2009 in “Reactions Weekly”

research LB793 A phase 1, open-Label, single ascending dose study in healthy subjects of the safety, tolerability and pharmacokinetics of ASLAN004, a novel IgG anti-IL-13 receptor alpha 1 Inhibitor

1 citations , August 2021 in “Journal of Investigative Dermatology”

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

← Previous page Next page →